Predicting the public health impact of a malaria transmission-blocking vaccine - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2021

Predicting the public health impact of a malaria transmission-blocking vaccine

Joseph Challenger
Daniela Olivera Mesa
Dari Da
R. Serge Yerbanga
Thomas Churcher

Résumé

Abstract Transmission-blocking vaccines that interrupt malaria transmission from humans to mosquitoes are being tested in early clinical trials. The activity of such a vaccine is commonly evaluated using membrane-feeding assays. Understanding the field efficacy of such a vaccine requires knowledge of how heavily infected wild, naturally blood-fed mosquitoes are, as this indicates how difficult it will be to block transmission. Here we use data on naturally infected mosquitoes collected in Burkina Faso to translate the laboratory-estimated activity into an estimated activity in the field. A transmission dynamics model is then utilised to predict a transmission-blocking vaccine’s public health impact alongside existing interventions. The model suggests that school-aged children are an attractive population to target for vaccination. Benefits of vaccination are distributed across the population, averting the greatest number of cases in younger children. Utilising a transmission-blocking vaccine alongside existing interventions could have a substantial impact against malaria.
Fichier principal
Vignette du fichier
s41467-021-21775-3.pdf (1.67 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03450550 , version 1 (26-11-2021)

Identifiants

Citer

Joseph Challenger, Daniela Olivera Mesa, Dari Da, R. Serge Yerbanga, Thierry Lefèvre, et al.. Predicting the public health impact of a malaria transmission-blocking vaccine. Nature Communications, 2021, 12 (1), ⟨10.1038/s41467-021-21775-3⟩. ⟨hal-03450550⟩
28 Consultations
29 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More